|
Volumn 19, Issue 8, 2011, Pages 2633-2640
|
Synthesis and biological evaluation of 1-substituted-3(5)-(6-methylpyridin- 2-yl)-4-(quinolin-6-yl)pyrazoles as transforming growth factor-β type 1 receptor kinase inhibitors
|
Author keywords
ALK5 inhibitor; Cancer; Cell based luciferase reporter assay; Fibrosis; Kinase assay; TGF
|
Indexed keywords
2 [3 (6 METHYLPYRIDIN 2 YL) 4 (QUINOLIN 6 YL) 1H PYRAZOL 1 YL] N PHENYLACETAMIDE;
2 [3 (6 METHYLPYRIDIN 2 YL) 4 (QUINOLIN 6 YL) 1H PYRAZOL 1 YL] N PHENYLETHANETHIOAMIDE;
2 [4 (4 METHOXYQUINOLIN 6 YL) 3 (6 METHYLPYRIDIN 2 YL) 1H PYRAZOL 1 YL] N PHENYLACETAMIDE;
2 [4 (4 METHOXYQUINOLIN 6 YL) 5 (6 METHYLPYRIDIN 2 YL) 1H PYRAZOL 1 YL] N PHENYLACETAMIDE;
2 [5 (6 METHYLPYRIDIN 2 YL) 4 (QUINOLIN 6 YL) 1H PYRAZOL 1 YL] N PHENYLACETAMIDE;
3 (3 CYANOPHENYL) 3 [3 (6 METHYLPYRIDIN 2 YL) 4 (QUINOLIN 6 YL) 1H PYRAZOL 1 YL]PROPANAMIDE;
3 [2 [3 (6 METHYLPYRIDIN 2 YL) 4 (QUINOLIN 6 YL) 1H PYRAZOL YL] 1H PYRAZOL ACETAMIDO]BENZAMIDE;
3 [2 [5 (6 METHYLPYRIDIN 2 YL) 4 (QUINOLIN 6 YL) 1H PYRAZOL 1 YL]ACETAMIDO]BENZAMIDE;
3 [3 (6 METHYLPYRIDIN 2 YL) 4 (QUINOLIN 6 YL) 1H PYRAZOL 1 YL] N PHENYLPROPANAMIDE;
3 [3 (6 METHYLPYRIDIN 2 YL) 4 (QUINOLIN 6 YL) 1H PYRAZOL 1 YL] N PHENYLPROPANETHIOAMIDE;
3(5) (6 METHYLPYRIDIN 2 YL) 4 (QUINOLIN 6 YL)PYRAZOLE DERIVATIVE;
LUCIFERASE;
N (3 CYANOPHENYL) 2 [3 (6 METHYLPYRIDIN 2 YL) 4 (QUINOLIN 6 YL) 1H PYRAZOL 1 YL]ACETAMIDE;
N (3 CYANOPHENYL) 2 [3 (6 METHYLPYRIDIN 2 YL) 4 (QUINOLIN 6 YL) 1H PYRAZOL 1 YL]ETHANETHIOAMIDE;
N (3 CYANOPHENYL) 2 [4 (4 METHOXYQUINOLIN 6 YL) 3 (6 METHYLPYRIDIN 2 YL) 1H PYRAZOL 1 YL]ACETAMIDE;
N (3 CYANOPHENYL) 2 [4 (4 METHOXYQUINOLIN 6 YL) 5 (6 METHYLPYRIDIN 2 YL) 1H PYRAZOL 1 YL]ACETAMIDE;
N (3 CYANOPHENYL) 2 [5 (6 METHYLPYRIDIN 2 YL) 4 (QUINOLIN 6 YL) 1H PYRAZOL 1 YL]ACETAMIDE;
N (3 CYANOPHENYL) 3 [3 (6 METHYLPYRIDIN 2 YL) 4 (QUINOLIN 6 YL) 1H PYRAZOL 1 YL]PROPANAMIDE;
N (3 CYANOPHENYL) 3 [3 (6 METHYLPYRIDIN 2 YL) 4 (QUINOLIN 6 YL) 1H PYRAZOL 1 YL]PROPANETHIOAMIDE;
N (3 CYANOPHENYL) 3 [4 (4 METHOXYQUINOLIN 6 YL) 3 (6 METHYLPYRIDIN 2 YL) 1H PYRAZOL 1 YL]PROPANAMIDE;
PROTEIN TYROSINE KINASE INHIBITOR;
TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1;
UNCLASSIFIED DRUG;
ARTICLE;
CHEMICAL MODIFICATION;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ENZYME ASSAY;
ENZYME INHIBITION;
ENZYME PHOSPHORYLATION;
GENETIC TRANSFECTION;
HUMAN;
HUMAN CELL;
IC 50;
KERATINOCYTE;
PROTON NUCLEAR MAGNETIC RESONANCE;
REPORTER GENE;
CELL LINE;
ENZYME ASSAYS;
HUMANS;
PHOSPHORYLATION;
PROTEIN KINASE INHIBITORS;
PROTEIN-SERINE-THREONINE KINASES;
PYRAZOLES;
RECEPTORS, TRANSFORMING GROWTH FACTOR BETA;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 79954425264
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmc.2011.03.008 Document Type: Article |
Times cited : (31)
|
References (40)
|